Interleukin-22 Is Required For Promotion Of K-Ras Mutant Lung Cancer

被引：0
|
作者：
Khosravi, N. [1 ]
Cumpian, A. M. [1 ]
Caetano, M. [1 ]
Daliri, S. [1 ]
Moghaddam, S. J. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3669
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of interleukin-22 on K-ras mutant lung cancer promotion and stemness properties
    Khosravi, Nasim
    Cumpian, Amber M.
    Daliri, Soudabeh
    Caetano, Mauricio S.
    Moghaddam, Seyed Javad
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S26 - S27
  • [2] Impact Of Interleukin-22 On K-Ras Mutant Lung Cancer Promotion And Stemness Properties
    Khosravi, N.
    Cumpian, A. M.
    Daliri, S.
    Caetano, M. S.
    Moghaddam, S. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] Impact of Interleukin-22 on K-ras mutant lung tumor microenvironment and sternness properties
    Khosravi, Nasim
    Cumpian, Amber M.
    Daliri, Soudabeh
    De La Garza, Cynthia
    Caetano, Mauricio S.
    Moghaddam, Seyed Javad
    CANCER RESEARCH, 2016, 76
  • [4] Muc5ac plays an essential role in promotion of k-ras mutant lung cancer
    Umer, Misha
    Cumpian, Amber M.
    Khosravi, Nasim
    Azzegagh, Zoulikha
    Mohebnasab, Maede
    Caetano, Mauricio S.
    Ostrin, Edwin J.
    Wistuba, Ignacio I.
    Dickey, Burton
    Kadara, Humam
    Evans, Christopher M.
    Moghaddam, Seyed J.
    CANCER RESEARCH, 2017, 77
  • [5] K-Ras is required for maintaining survivin protein stability in human cancer cells harboring mutant but not wild type K-Ras
    Tecleab, Awet
    Sebti, Said M.
    CANCER RESEARCH, 2011, 71
  • [6] Targeting tumor microenvironment for treatment of K-ras mutant lung cancer
    Caetano, Mauricio da Silva
    Chang, Seon Hee
    Cumpian, Amber M.
    Daliri, Soudabeh
    De La Garza, Maria Miguelina
    Ochoa, Cesar E.
    Dong, Chen
    Moghaddam, Seyed Javad
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [7] Impact of interleukin-22 in human lung cancer
    Kobold, S.
    Voelk, S.
    Clauditz, T.
    Kuepper, N. J.
    Minner, S.
    Tufman, A.
    Duewell, P.
    Lindner, M.
    Koch, I
    Merk, M.
    Heidegger, S.
    Rothenfusser, S.
    Schnurr, M.
    Huber, R. M.
    Sauter, G.
    Wilczak, W.
    Endres, S.
    ONKOLOGIE, 2012, 35 : 136 - 136
  • [8] Interleukin-22 is expressed by lung cancer cells
    Kobold, S.
    Minner, S.
    Voelk, S.
    Duewell, P.
    Merk, M.
    Tufman, A.
    Huber, R. M.
    Bourquin, C.
    Schnurr, M.
    Sauter, G.
    Endres, S.
    ONKOLOGIE, 2011, 34 : 121 - 121
  • [9] Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
    Hua Jin
    Yoonjeong Jang
    Nian Cheng
    Qing Li
    Peng-Fei Cui
    Zhi-Wei Zhou
    Hu-Lin Jiang
    Myung-Haing Cho
    Kenneth D. Westover
    Qun-You Tan
    Cheng-Xiong Xu
    Journal of Experimental & Clinical Cancer Research, 38
  • [10] A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells
    Martin, Timothy D.
    Cook, Danielle R.
    Choi, Mei Yuk
    Li, Mamie Z.
    Haigis, Kevin M.
    Elledge, Stephen J.
    CELL REPORTS, 2017, 20 (02): : 427 - 438
12345